Skip to main content
letter
. 2019 Feb 22;29:100521. doi: 10.1016/j.nmni.2019.100521

Table 1.

Phenotypic and genotypic features of carbapenem-resistant clinical isolates

Pseudomonas aeruginosa strain Source Antibiotic resistance profile IMP MIC (μg/mL) Carba NP test VIM-2 ST
PA-3 Rectal swab TIC, TCC, TZP, CAZ, FEP, IMP, ERT, AK, TOB, CIP, F, DO, SXT, R >32 + + 357
PA-16 Rectal swab TIC, TCC, TZP, CAZ, FEP, IMP, ERT, AK, TOB, CIP, F, DO, SXT, R >32 + + 357
PA-6 Rectal swab TIC, TCC, TZP, CAZ, FEP, IMP, ERT, AK, TOB, CIP, F, DO, SXT, R >32 + + 357
PA-4 Rectal swab TIC, TCC, TZP, CAZ, FEP, IMP, ERT, AK, TOB, CIP, F, DO, SXT,R >32 + − 233

AK, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; DO, doxycycline; ERT, ertapenem; F, nitrofurantoin; FEP, cefepime; FF, fosfomycin; IPM, imipenem; R, rifampicin; ST, sequence, type; SXT, trimethoprim/sulfamethoxazole; TCC, ticarcillin/clavulanic, acid; TIC, ticarcillin; TOB, tobramycin; TZP, piperacillin/tazobactam.